Arun Kumar Mahanta

2.7k total citations · 1 hit paper
16 papers, 2.1k citations indexed

About

Arun Kumar Mahanta is a scholar working on Biomaterials, Biomedical Engineering and Organic Chemistry. According to data from OpenAlex, Arun Kumar Mahanta has authored 16 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biomaterials, 7 papers in Biomedical Engineering and 3 papers in Organic Chemistry. Recurrent topics in Arun Kumar Mahanta's work include Nanoparticle-Based Drug Delivery (5 papers), Graphene and Nanomaterials Applications (4 papers) and Bone Tissue Engineering Materials (3 papers). Arun Kumar Mahanta is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Graphene and Nanomaterials Applications (4 papers) and Bone Tissue Engineering Materials (3 papers). Arun Kumar Mahanta collaborates with scholars based in India, United States and United Kingdom. Arun Kumar Mahanta's co-authors include Pralay Maiti, Sudipta Senapati, Sunil Kumar, Dinesh K. Patel, Mohan Kumar, Nitesh Singh, Debabrata Dash, Vikas Mittal, Sudip Malik and Bivek Chaulagain and has published in prestigious journals such as Macromolecules, International Journal of Molecular Sciences and Journal of Applied Polymer Science.

In The Last Decade

Arun Kumar Mahanta

15 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Controlled drug delivery vehicles for cancer treatment and their performance

2018 1.7k citations Sudipta Senapati, Arun Kumar Mahanta et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Arun Kumar Mahanta

Since Specialization

Citations

This map shows the geographic impact of Arun Kumar Mahanta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arun Kumar Mahanta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arun Kumar Mahanta more than expected).

Fields of papers citing papers by Arun Kumar Mahanta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arun Kumar Mahanta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arun Kumar Mahanta. The network helps show where Arun Kumar Mahanta may publish in the future.

Co-authorship network of co-authors of Arun Kumar Mahanta

This figure shows the co-authorship network connecting the top 25 collaborators of Arun Kumar Mahanta. A scholar is included among the top collaborators of Arun Kumar Mahanta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arun Kumar Mahanta. Arun Kumar Mahanta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Engineered PLGA Nanoparticles for Brain-Targeted Codelivery of Cannabidiol and pApoE2 through the Intranasal Route for the Treatment of Alzheimer’s Disease 2025 ·ACS Biomaterials Science & Engineering ·Arun Kumar Mahanta, Bivek Chaulagain, Avinash Gothwal, Jagdish Singh	2
2	Emerging anti-inflammatory nanosystems targeted to the brain 2025 ·Nanomedicine ·Arun Kumar Mahanta, Avinash Gothwal, Bivek Chaulagain, (unknown), (unknown), (unknown), (unknown), Jagdish Singh	0
3	Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease 2024 ·Frontiers in Pharmacology ·(unknown), Bivek Chaulagain, Avinash Gothwal, Arun Kumar Mahanta, (unknown), (unknown), Jagdish Singh	12
4	Mannose-Functionalized Chitosan-Coated PLGA Nanoparticles for Brain-Targeted Codelivery of CBD and BDNF for the Treatment of Alzheimer’s Disease 2024 ·ACS Chemical Neuroscience ·Arun Kumar Mahanta, Bivek Chaulagain, Riddhi Trivedi, Jagdish Singh	15
5	Experimental Models of In Vitro Blood–Brain Barrier for CNS Drug Delivery: An Evolutionary Perspective 2023 ·International Journal of Molecular Sciences ·Bivek Chaulagain, Avinash Gothwal, Richard Nii Lante Lamptey, Riddhi Trivedi, Arun Kumar Mahanta, Buddhadev Layek, Jagdish Singh	30
6	Biocompatible fluorescent probe for detecting mitochondrial alkaline phosphatase activity in live cells 2020 ·Journal of Photochemistry and Photobiology B Biology ·(unknown), (unknown), Arun Kumar Mahanta, Manu M. Joseph, (unknown), Arup Podder, Pralay Maiti, Kaustabh Kumar Maiti, Sankarprasad Bhuniya	12
7	Functionalized polyvinyl chloride/layered double hydroxide nanocomposites and its thermal and mechanical properties 2020 ·Journal of Applied Polymer Science ·B. N. Singh, Divya Somvanshi, Rajesh Kumar Singh, Arun Kumar Mahanta, Pralay Maiti, (unknown), Pradip Paik	14
8	A binuclear chloride bridged Cu(II) and a mononuclear Ni(II) complex: Synthesis, crystal structure, photo catalytic and biological studies 2020 ·Inorganica Chimica Acta ·(unknown), (unknown), Horst Puschmann, Anindita Mitra, Rita Ghosh, Subhas Chandra Debnath, Aparna Shukla, Arun Kumar Mahanta, Tithi Maity, Bidhan Chandra Samanta	16
9	Nanohybrid Scaffold of Chitosan and Functionalized Graphene Oxide for Controlled Drug Delivery and Bone Regeneration 2019 ·ACS Biomaterials Science & Engineering ·Arun Kumar Mahanta, Dinesh K. Patel, Pralay Maiti	47
10	Injectable Hydrogel through Hydrophobic Grafting on Chitosan for Controlled Drug Delivery 2019 ·ACS Applied Bio Materials ·Arun Kumar Mahanta, Pralay Maiti	42
11	Nanoparticle-Induced Controlled Drug Delivery Using Chitosan-Based Hydrogel and Scaffold: Application to Bone Regeneration 2018 ·Molecular Pharmaceutics ·Arun Kumar Mahanta, Sudipta Senapati, (unknown), Sairam Krishnamurthy, S Hemalatha, Pralay Maiti	60
12	Controlled drug delivery vehicles for cancer treatment and their performance breakdown → 2018 ·Signal Transduction and Targeted Therapy ·Sudipta Senapati, Arun Kumar Mahanta, Sunil Kumar, Pralay Maiti	1653
13	Cell proliferation influenced by matrix compliance of gelatin grafted poly(d,l-Lactide) three dimensional scaffolds 2018 ·Colloids and Surfaces B Biointerfaces ·Chelladurai Karthikeyan Balavigneswaran, Sanjeev Kumar Mahto, Arun Kumar Mahanta, Rajshree Singh, Mahalingam Rajamanickam Vijayakumar, Biswajit Ray, Nira Misra	15
14	Supramolecular self-assembly, DNA interaction, antibacterial and cell viability studies of Cu(II) and Ni(II) complexes derived from NNN donor Schiff base ligand 2018 ·Inorganica Chimica Acta ·(unknown), Somnath Das, Horst Puschmann, Subhas Chandra Debnath, Aparna Shukla, Arun Kumar Mahanta, Maidul Hossain, Tithi Maity, Bidhan Chandra Samanta	26
15	Engineered Cellular Uptake and Controlled Drug Delivery Using Two Dimensional Nanoparticle and Polymer for Cancer Treatment 2018 ·Molecular Pharmaceutics ·Sudipta Senapati, (unknown), Yamini Bhusan Tripathi, Arun Kumar Mahanta, Dipak Rana, Pralay Maiti	45
16	Polyurethane-Grafted Chitosan as New Biomaterials for Controlled Drug Delivery 2015 ·Macromolecules ·Arun Kumar Mahanta, Vikas Mittal, Nitesh Singh, Debabrata Dash, Sudip Malik, Mohan Kumar, Pralay Maiti	88

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact